cryo-cell.com (CCEL): רווחיות תפעולית

לוגו של חברה ציבורית Cryo-Cell International Inc (CCEL)

The EBIT margin chart demonstrates the profit dynamics of Cryo-Cell International (CCEL), which relies on the development of cell therapy in partnership with Duke University. The 0.60 metric indicates the efficiency status of the business, which is based on stable biobanking payments. Crisis resilience is driven by the perception of storage as insurance, while reliability is guaranteed by automated cryopreservation systems operating on a 24/7 basis.

Cryo-Cell International (CCEL): רווחיות תפעולית מ-04.07.2022 עד 19.11.2026

CCEL (Cryo-Cell International Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים

- מחיר מניה וקונצנזוס הערכת שווי:
- נתוני שווי שוק בבורסה:
ניתוח כללי של החברה:Cryo-Cell International
מוצרים מוגמרים של Cryo-Cell

Operating margin measures cost management efficiency, reflecting the share of profit from core operations before interest and taxes relative to total revenue. The EBIT margin trend allows for an assessment of Cryo-Cell International (CCEL) resilience to regulatory risks, confirming that the high profitability of biomaterial storage services offsets operating expenses and supports the company's capitalization.